Qian Shi

16.3k total citations · 3 hit papers
332 papers, 8.2k citations indexed

About

Qian Shi is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qian Shi has authored 332 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Oncology, 96 papers in Pathology and Forensic Medicine and 80 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qian Shi's work include Colorectal Cancer Treatments and Studies (131 papers), Genetic factors in colorectal cancer (78 papers) and Colorectal Cancer Surgical Treatments (45 papers). Qian Shi is often cited by papers focused on Colorectal Cancer Treatments and Studies (131 papers), Genetic factors in colorectal cancer (78 papers) and Colorectal Cancer Surgical Treatments (45 papers). Qian Shi collaborates with scholars based in United States, France and United Kingdom. Qian Shi's co-authors include Daniel J. Sargent, Steven R. Alberts, Frank A. Sinicrope, Richard M. Goldberg, Steven W. Anderson, Jeffrey D. Dawson, Axel Grothey, Harry H. Yoon, Manuchair Ebadi and Garth D. Nelson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Qian Shi

307 papers receiving 8.0k citations

Hit Papers

Prognosis of patients with peritoneal metastatic colorect... 2011 2026 2016 2021 2016 2011 2022 100 200 300 400

Peers

Qian Shi
Lee S. Schwartzberg United States
Sijin Wen United States
Matthew J. Grainge United Kingdom
David Harrington United States
John Simes Australia
James L. Wade United States
Lee S. Schwartzberg United States
Qian Shi
Citations per year, relative to Qian Shi Qian Shi (= 1×) peers Lee S. Schwartzberg

Countries citing papers authored by Qian Shi

Since Specialization
Citations

This map shows the geographic impact of Qian Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Shi more than expected).

Fields of papers citing papers by Qian Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qian Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Shi. The network helps show where Qian Shi may publish in the future.

Co-authorship network of co-authors of Qian Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Qian Shi. A scholar is included among the top collaborators of Qian Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qian Shi. Qian Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Zhenwei, et al.. (2025). Persistent lipoprotein(a) exposure and its association with clinical outcomes after acute myocardial infarction: a longitudinal cohort study. Annals of Medicine. 57(1). 2454975–2454975. 3 indexed citations
3.
Lian, Meng, Jiaming Chen, Xixi Shen, et al.. (2024). Investigating the impact of clinical and genetic factors on the post-surgery prognosis of sinonasal squamous cell carcinoma. Scientific Reports. 14(1). 22167–22167. 2 indexed citations
4.
Jin, Zhaohui, Kathryn J. Ruddy, Deirdre R. Pachman, et al.. (2024). Symptom burden in adolescents and young adults with cancer: A subgroup analysis of the enhanced, EHR-facilitated cancer symptom control (E2C2) trial.. Journal of Clinical Oncology. 42(16_suppl). 12065–12065.
5.
Zemla, Tyler, Nguyen H. Tran, Krishan R. Jethwa, et al.. (2024). Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal Cancer. JCO Precision Oncology. 8(8). e2300127–e2300127. 6 indexed citations
6.
Paiva, Bruno, Jorge M. Núñez‐Córdoba, Paula Rodríguez‐Otero, et al.. (2023). Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma. Blood Advances. 8(1). 219–223. 11 indexed citations
7.
Brown, Justin C., Qian Shi, Donna Niedzwiecki, et al.. (2023). Association between physical activity and the time course of cancer recurrence in stage III colon cancer. British Journal of Sports Medicine. 57(15). 965–971. 19 indexed citations
8.
Shi, Qian, et al.. (2023). Atorvastatin mitigates memory deficits and brain monocyte infiltration in chronic hypercholesterolemia. Aging. 15(23). 13669–13679. 3 indexed citations
9.
Weiser, Martin R., Qian Shi, George J. Chang, et al.. (2023). 597P Surgical quality for patients (pts) treated with neoadjuvant chemotherapy vs chemoradiation for locally advanced rectal cancer (LARC): PROSPECT (NCCTG N1048, alliance). Annals of Oncology. 34. S431–S432. 1 indexed citations
10.
Edelmann, Dominic, Federico Canzian, Petra Seibold, et al.. (2023). Genome‐wide study of genetic polymorphisms predictive for outcome from first‐line oxaliplatin‐based chemotherapy in colorectal cancer patients. International Journal of Cancer. 153(9). 1623–1634. 1 indexed citations
11.
Lee, Seohyuk, Qian Shi, Pankaj Kumar, et al.. (2022). Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702. Journal of Clinical Oncology. 41(5). 1079–1091. 10 indexed citations
12.
Casulo, Carla, Jesse G. Dixon, Fang‐Shu Ou, et al.. (2021). Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials. Blood Advances. 5(6). 1737–1745. 3 indexed citations
13.
Wang, Ru, Shizhi He, Qi Zhong, et al.. (2020). Induction chemotherapy for the individualised treatment of hypopharyngeal carcinoma with cervical oesophageal invasion: a retrospective cohort study. World Journal of Surgical Oncology. 18(1). 330–330. 5 indexed citations
14.
Yoon, Harry H., Qian Shi, Erica N. Heying, et al.. (2018). Intertumoral Heterogeneity of CD3+ and CD8+ T-Cell Densities in the Microenvironment of DNA Mismatch-Repair–Deficient Colon Cancers: Implications for Prognosis. Clinical Cancer Research. 25(1). 125–133. 63 indexed citations
15.
Shi, Qian, Peter Lee, Hui Shao, et al.. (2017). Evaluation of the Quality Blue Primary Care program on health outcomes.. PubMed. 23(12). e402–e408. 2 indexed citations
16.
Sargent, Daniel J., Qian Shi, Sharlene Gill, et al.. (2014). Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter Study. Clinical Cancer Research. 20(16). 4361–4369. 8 indexed citations
17.
Phipps, Amanda I., Qian Shi, Polly A. Newcomb, et al.. (2013). Associations Between Cigarette Smoking Status and Colon Cancer Prognosis Among Participants in North Central Cancer Treatment Group Phase III Trial N0147. Journal of Clinical Oncology. 31(16). 2016–2023. 44 indexed citations
18.
Hubbard, Joleen M., David M. Thomas, Greg Yothers, et al.. (2012). Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set. Journal of Clinical Oncology. 30(19). 2334–2339. 32 indexed citations
19.
Yoon, Harry H., Mark A. Lewis, Qian Shi, et al.. (2011). Prognostic Impact of Body Mass Index Stratified by Smoking Status in Patients With Esophageal Adenocarcinoma. Journal of Clinical Oncology. 29(34). 4561–4567. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026